• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病的治疗:最新进展。第1部分:心血管疾病危险因素概述。

The treatment of coronary heart disease: an update. Part 1: An overview of the risk factors for cardiovascular disease.

作者信息

Elisaf M

机构信息

Department of Internal Medicine, Medical School, University of Ioannina, Ioannina 451 10, Greece.

出版信息

Curr Med Res Opin. 2001;17(1):18-26.

PMID:11464441
Abstract

Cardiovascular disease (CVD) is the main cause of death. Atherosclerosis of coronary arteries is responsible for almost all cases of CVD. The term 'risk factor' describes all those characteristics found in healthy individuals that are independently related to subsequent development of CVD. It includes modifiable biochemical and physiological characteristics, such as hypercholesterolaemia, hypertension, cigarette smoking, diabetes mellitus, obesity and low HDL cholesterol levels, as well as non-modifiable personal characteristics, such as age, gender and family or personal history of early onset CVD. In addition to the 'classic' risk factors mentioned above, several other variables have been implicated as predictors of CVD: left ventricular hypertrophy; infectious agents; markers of inflammation; oxidative stress; and increased levels of fibrinogen, triglycerides, homocysteine and Lp(a)]. However, controversy exists regarding the exact role of these variables in the pathogenesis of atherosclerosis. Furthermore, there are no conclusive data showing that the modification of these variables is associated with a decrease in the incidence of cardiovascular events. Nevertheless, these 'new' risk factors should be taken into account in patients with CVD without established risk factors.

摘要

心血管疾病(CVD)是主要的死亡原因。冠状动脉粥样硬化几乎是所有心血管疾病病例的病因。“危险因素”一词描述了在健康个体中发现的所有那些与心血管疾病随后发生独立相关的特征。它包括可改变的生化和生理特征,如高胆固醇血症、高血压、吸烟、糖尿病、肥胖和低高密度脂蛋白胆固醇水平,以及不可改变的个人特征,如年龄、性别以及早发性心血管疾病的家族史或个人史。除了上述“经典”危险因素外,还有其他几个变量被认为是心血管疾病的预测指标:左心室肥厚;感染因子;炎症标志物;氧化应激;以及纤维蛋白原、甘油三酯、同型半胱氨酸和脂蛋白(a)水平升高。然而,关于这些变量在动脉粥样硬化发病机制中的确切作用存在争议。此外,没有确凿的数据表明改变这些变量与心血管事件发生率的降低有关。尽管如此,对于没有既定危险因素的心血管疾病患者,应考虑这些“新”危险因素。

相似文献

1
The treatment of coronary heart disease: an update. Part 1: An overview of the risk factors for cardiovascular disease.冠心病的治疗:最新进展。第1部分:心血管疾病危险因素概述。
Curr Med Res Opin. 2001;17(1):18-26.
2
Critical appraisal of inflammatory markers in cardiovascular risk stratification.炎症标志物在心血管风险分层中的评价。
Crit Rev Clin Lab Sci. 2014 Oct;51(5):263-79. doi: 10.3109/10408363.2014.913549. Epub 2014 Jun 11.
3
[Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].[2000年西班牙的胆固醇血症控制。心血管疾病预防工具。卫生与消费部、西班牙心脏病学会和西班牙动脉硬化学会]
Rev Esp Salud Publica. 2000 May-Jun;74(3):215-53.
4
The value of lipoprotein (a), homocysteine, and Doppler of carotid and femoral arteries in assessment of atherosclerosis in asymptomatic cardiovascular risk patients.脂蛋白 (a)、同型半胱氨酸、颈动脉和股动脉多普勒在无症状心血管风险患者动脉粥样硬化评估中的价值。
J Cardiol. 2008 Dec;52(3):202-11. doi: 10.1016/j.jjcc.2008.08.001. Epub 2008 Sep 18.
5
An update on the burden of cardiovascular disease risk factors in Jamaica: findings from the Jamaica Health and Lifestyle Survey 2007-2008.牙买加心血管疾病风险因素负担的最新情况:2007 - 2008年牙买加健康与生活方式调查结果
West Indian Med J. 2011 Jul;60(4):422-8.
6
Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms.心理困扰作为心血管事件的危险因素:病理生理和行为机制
J Am Coll Cardiol. 2008 Dec 16;52(25):2156-62. doi: 10.1016/j.jacc.2008.08.057.
7
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.管理他汀类药物治疗患者与高密度脂蛋白胆固醇和甘油三酯相关的残余心血管疾病风险:临床更新。
Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):799-807. doi: 10.1016/j.numecd.2013.05.002. Epub 2013 Aug 9.
8
Cardiovascular risk factors in women with and without rheumatoid arthritis.患有和未患类风湿关节炎女性的心血管危险因素。
Arthritis Rheum. 2004 Nov;50(11):3444-9. doi: 10.1002/art.20636.
9
Sex differences in cardiovascular risk factors and disease prevention.心血管危险因素与疾病预防中的性别差异。
Atherosclerosis. 2015 Jul;241(1):211-8. doi: 10.1016/j.atherosclerosis.2015.01.027. Epub 2015 Jan 28.
10
Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.LURIC研究的基本原理与设计——心血管疾病功能基因组学、药物基因组学及长期预后的资源
Pharmacogenomics. 2001 Feb;2(1 Suppl 1):S1-73. doi: 10.1517/14622416.2.1.S1.

引用本文的文献

1
Rising unemployment reduces the demand for healthcare services among people with cardiovascular disease: an Australian cohort study.失业率上升降低了心血管疾病患者对医疗服务的需求:一项澳大利亚队列研究。
Eur J Health Econ. 2021 Jun;22(4):643-658. doi: 10.1007/s10198-021-01281-5. Epub 2021 Mar 19.
2
Commentary: Time for a paradigm shift in conceptualizing risk factors in sports injury research.评论:体育损伤研究中风险因素概念化的范式转变时机已到。
J Athl Train. 2010 Jan-Feb;45(1):58-60. doi: 10.4085/1062-6050-45.1.58.
3
Hypertension control and co-morbidities in primary health care centers in Riyadh.
利雅得初级卫生保健中心的高血压控制与合并症
Ann Saudi Med. 2006 Jul-Aug;26(4):266-71. doi: 10.5144/0256-4947.2006.266.
4
Derivative ratio as a measure of effect: sex over age of occurrence of myocardial infarction in Brazil.
Eur J Epidemiol. 2006;21(4):263-6. doi: 10.1007/s10654-006-0021-y.
5
Heart disease attributions: introduction to the miniseries.心脏病归因:迷你剧介绍
Int J Behav Med. 2005;12(1):21-3. doi: 10.1207/s15327558ijbm1201_3.
6
Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?欧洲普通人群中风预测研究(EUROSTROKE):纤维蛋白原和心电图有作用吗?
J Epidemiol Community Health. 2002 Feb;56 Suppl 1(Suppl 1):i30-6. doi: 10.1136/jech.56.suppl_1.i30.